Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of cinitapride for functional dyspepsia
ChiCTR2000030949Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinitapride in functional dyspepsia (FD), sponsored by Ruijin Hospital. Primary endpoints: Total symptom improvement efficiency, Percentage change in total symptom score of functional dyspepsia and 3 more. Started Feb 2019; status: recruiting.
02
Drugs
cinitapride
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2000030949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030949.